<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35455952</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>09</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Lysosomes Dysfunction Causes Mitophagy Impairment in PBMCs of Sporadic ALS Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1272</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells11081272</ELocationID><Abstract><AbstractText>Mitochondria alterations are present in tissues derived from patients and animal models, but no data are available for peripheral blood mononuclear cells (PBMCs) of ALS patients. This work aims to investigate mitophagy in PBMCs of sporadic (sALS) patients and how this pathway can be tuned by using small molecules. We found the presence of morphologically atypical mitochondria by TEM and morphological abnormalities by MitoTracker&#x2122;. We found a decreased number of healthy mitochondria in sALS PBMCs and an impairment of mitophagy with western blot and immunofluorescence. After rapamycin treatment, we found a higher increase in the LC3 marker in sALS PBMCs, while after NH4Cl treatment, we found a lower increase in the LC3 marker. Finally, mTOR-independent autophagy induction with trehalose resulted in a significant decrease in the lysosomes level sALS PBMCs. Our data suggest that the presence of morphologically altered mitochondria and an inefficient turnover of damaged mitochondria in PBMCs of sALS patients rely on the impairment of the mitophagy pathway. We also found that the induction of the mTOR-independent autophagy pathway leads to a decrease in lysosomes level, suggesting a more sensitivity of sALS PBMCs to trehalose. Such evidence suggests that trehalose could represent an effective treatment for ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bordoni</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9461-756X</Identifier><AffiliationInfo><Affiliation>Genomic and Post-Genomic Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pansarasa</LastName><ForeName>Orietta</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-3041-0612</Identifier><AffiliationInfo><Affiliation>Genomic and Post-Genomic Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarian</LastName><ForeName>Eveljn</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6703-1755</Identifier><AffiliationInfo><Affiliation>Genomic and Post-Genomic Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cristofani</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2719-846X</Identifier><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Dipartimento di Eccellenza 2018-2022, Universit&#xe0; Degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leone</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Casa di Cura Ars Medica S.p.a, 00191 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fantini</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-1244-4453</Identifier><AffiliationInfo><Affiliation>Laboratory of Neurobiology and Neurogenetic, Golgi-Cenci Foundation, 20081 Abbiategrasso, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8668-3855</Identifier><AffiliationInfo><Affiliation>Genomic and Post-Genomic Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diamanti</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neuroncology Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernuzzi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Immunohematological and Transfusional Service and Centre of Transplantation Immunology, IRCCS "San Matteo Foundation", 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagliardi</LastName><ForeName>Stella</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6589-6907</Identifier><AffiliationInfo><Affiliation>Genomic and Post-Genomic Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carelli</LastName><ForeName>Stephana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4603-396X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, 20157 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Clinical Research Centre Fondazione "Romeo ed Enrica Invernizzi", University of Milano, 20157 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poletti</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8883-0468</Identifier><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Dipartimento di Eccellenza 2018-2022, Universit&#xe0; Degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cereda</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9571-0862</Identifier><AffiliationInfo><Affiliation>Genomic and Post-Genomic Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>B8WCK70T7I</RegistryNumber><NameOfSubstance UI="D014199">Trehalose</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063306" MajorTopicYN="Y">Mitophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014199" MajorTopicYN="N">Trehalose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">PBMCs</Keyword><Keyword MajorTopicYN="N">autolysosomes</Keyword><Keyword MajorTopicYN="N">mTOR</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">trehalose</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35455952</ArticleId><ArticleId IdType="pmc">PMC9030813</ArticleId><ArticleId IdType="doi">10.3390/cells11081272</ArticleId><ArticleId IdType="pii">cells11081272</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zucchi E., Ticozzi N., Mandrioli J. Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder. Front. Neurosci. 2019;13:175. doi: 10.3389/fnins.2019.00175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00175</ArticleId><ArticleId IdType="pmc">PMC6421303</ArticleId><ArticleId IdType="pubmed">30914912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., Van Den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S., Couratier P., Julian A., Corcia P., Le Masson G. Current view and perspectives in amyotrophic lateral sclerosis. Neural Regen. Res. 2017;12:181&#x2013;184. doi: 10.4103/1673-5374.200794.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.200794</ArticleId><ArticleId IdType="pmc">PMC5361492</ArticleId><ArticleId IdType="pubmed">28400790</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z., Sheehan P., Chen S., Yue Z. Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease? Mol. Neurodegener. 2017;12:90. doi: 10.1186/s13024-017-0232-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0232-6</ArticleId><ArticleId IdType="pmc">PMC5746010</ArticleId><ArticleId IdType="pubmed">29282133</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; M.T., D&#x2019;Ambrosi N., Cozzolino M. Pathways to mitochondrial dysfunction in ALS pathogenesis. Biochem. Biophys. Res. Commun. 2017;483:1187&#x2013;1193. doi: 10.1016/j.bbrc.2016.07.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.07.055</ArticleId><ArticleId IdType="pubmed">27416757</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls D.G., Budd S.L. Mitochondria and Neuronal Survival. Physiol. Rev. 2000;80:315&#x2013;360. doi: 10.1152/physrev.2000.80.1.315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.2000.80.1.315</ArticleId><ArticleId IdType="pubmed">10617771</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Velde C.V., Cleveland D.W. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M.J., Suh Y.-L. Ultrastructural Changes of Mitochondria in the Skeletal Muscle of Patients with Amyotrophic Lateral Sclerosis. Ultrastruct. Pathol. 2002;26:3&#x2013;7. doi: 10.1080/01913120252934260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01913120252934260</ArticleId><ArticleId IdType="pubmed">12028652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Iwata M. Mitochondrial Alterations in the Spinal Cord of Patients with Sporadic Amyotrophic Lateral Sclerosis. J. Neuropathol. Exp. Neurol. 2007;66:10&#x2013;16. doi: 10.1097/nen.0b013e31802c396b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e31802c396b</ArticleId><ArticleId IdType="pubmed">17204932</ArticleId></ArticleIdList></Reference><Reference><Citation>Westrate L.M., Drocco J.A., Martin K.R., Hlavacek W.S., MacKeigan J.P. Mitochondrial Morphological Features Are Associated with Fission and Fusion Events. PLoS ONE. 2014;9:e95265. doi: 10.1371/journal.pone.0095265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095265</ArticleId><ArticleId IdType="pmc">PMC3986258</ArticleId><ArticleId IdType="pubmed">24733410</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan D.C. Fusion and Fission: Interlinked Processes Critical for Mitochondrial Health. Annu. Rev. Genet. 2012;46:265&#x2013;287. doi: 10.1146/annurev-genet-110410-132529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-110410-132529</ArticleId><ArticleId IdType="pubmed">22934639</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W., Song Y., Kincaid B., Bossy B., Bossy-Wetzel E. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC-1&#x3b1;. Neurobiol. Dis. 2013;51:72&#x2013;81. doi: 10.1016/j.nbd.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.07.004</ArticleId><ArticleId IdType="pmc">PMC3992938</ArticleId><ArticleId IdType="pubmed">22819776</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.-L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano K., Matsuda N., Tanaka K. The ubiquitin signal and autophagy: An orchestrated dance leading to mitochondrial degradation. EMBO Rep. 2016;17:300&#x2013;316. doi: 10.15252/embr.201541486.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201541486</ArticleId><ArticleId IdType="pmc">PMC4772979</ArticleId><ArticleId IdType="pubmed">26882551</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Huang L., Lan J., Feng X., Li P., Wu L., Peng Y. Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases. Pharmacol. Res. 2020;163:105240. doi: 10.1016/j.phrs.2020.105240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105240</ArticleId><ArticleId IdType="pubmed">33053441</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes J.A., Davies M.C., Collins M.O. TBK1: A new player in ALS linking autophagy and neuroinflammation. Mol. Brain. 2017;10:5. doi: 10.1186/s13041-017-0287-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0287-x</ArticleId><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Zhou B., Lin M.-Y., Wang S., Foust K.D., Sheng Z.-H. Endolysosomal Deficits Augment Mitochondria Pathology in Spinal Motor Neurons of Asymptomatic fALS Mice. Neuron. 2015;87:355&#x2013;370. doi: 10.1016/j.neuron.2015.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.06.026</ArticleId><ArticleId IdType="pmc">PMC4511489</ArticleId><ArticleId IdType="pubmed">26182418</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarian E., Fiamingo G., Diamanti L., Palmieri I., Gagliardi S., Pansarasa O. The Role of VCP Mutations in the Spectrum of Amyotrophic Lateral Sclerosis&#x2014;Frontotemporal Dementia. Front. Neurol. 2022;13:271. doi: 10.3389/fneur.2022.841394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.841394</ArticleId><ArticleId IdType="pmc">PMC8902152</ArticleId><ArticleId IdType="pubmed">35273561</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O., Garofalo M., Scarian E., Dragoni F., Garau J., Di Gerlando R., Diamanti L., Bordoni M., Gagliardi S. Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2022;23:2580. doi: 10.3390/ijms23052580.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052580</ArticleId><ArticleId IdType="pmc">PMC8910056</ArticleId><ArticleId IdType="pubmed">35269723</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni M., Pansarasa O., Dell&#x2019;Orco M., Crippa V., Gagliardi S., Sproviero D., Bernuzzi S., Diamanti L., Ceroni M., Tedeschi G., et al. Nuclear Phospho-SOD1 Protects DNA from Oxidative Stress Damage in Amyotrophic Lateral Sclerosis. J. Clin. Med. 2019;8:729. doi: 10.3390/jcm8050729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8050729</ArticleId><ArticleId IdType="pmc">PMC6572067</ArticleId><ArticleId IdType="pubmed">31121901</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereda C., Leoni E., Milani P., Pansarasa O., Mazzini G., Guareschi S., Alvisi E., Ghiroldi A., Diamanti L., Bernuzzi S., et al. Altered Intracellular Localization of SOD1 in Leukocytes from Patients with Sporadic Amyotrophic Lateral Sclerosis. PLoS ONE. 2013;8:e75916. doi: 10.1371/journal.pone.0075916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075916</ArticleId><ArticleId IdType="pmc">PMC3796534</ArticleId><ArticleId IdType="pubmed">24155874</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Zucca S., Pandini C., Diamanti L., Bordoni M., Sproviero D., Arigoni M., Olivero M., Pansarasa O., Ceroni M., et al. Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients. Sci. Rep. 2018;8:2378. doi: 10.1038/s41598-018-20679-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20679-5</ArticleId><ArticleId IdType="pmc">PMC5799454</ArticleId><ArticleId IdType="pubmed">29402919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A., Drory V., Hardiman O., Nakano I., Ravits J., Robberecht W., Shefner J. A revision of the El Escorial criteria&#x2014;2015. Amyotroph. Lateral Scler. Front. Degener. 2015;16:291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Necchi V., Sommi P., Ricci V., Solcia E. In Vivo Accumulation of Helicobacter pylori Products, NOD1, Ubiquitinated Proteins and Proteasome in a Novel Cytoplasmic Structure. PLoS ONE. 2010;5:e9716. doi: 10.1371/journal.pone.0009716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009716</ArticleId><ArticleId IdType="pmc">PMC2838800</ArticleId><ArticleId IdType="pubmed">20300534</ArticleId></ArticleIdList></Reference><Reference><Citation>Guareschi S., Cova E., Cereda C., Ceroni M., Donetti E., Bosco D.A., Trotti D., Pasinelli P. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc. Natl. Acad. Sci. USA. 2012;109:5074&#x2013;5079. doi: 10.1073/pnas.1115402109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115402109</ArticleId><ArticleId IdType="pmc">PMC3324021</ArticleId><ArticleId IdType="pubmed">22416121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall A.R., Burke N., Dongworth R.K., Hausenloy D.J. Mitochondrial fusion and fission proteins: Novel therapeutic targets for combating cardiovascular disease. J. Cereb. Blood Flow Metab. 2014;171:1890&#x2013;1906. doi: 10.1111/bph.12516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12516</ArticleId><ArticleId IdType="pmc">PMC3976611</ArticleId><ArticleId IdType="pubmed">24328763</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliuso A., Cossart P., Stavru F. The ever-growing complexity of the mitochondrial fission machinery. Cell. Mol. Life Sci. 2018;75:355&#x2013;374. doi: 10.1007/s00018-017-2603-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2603-0</ArticleId><ArticleId IdType="pmc">PMC5765209</ArticleId><ArticleId IdType="pubmed">28779209</ArticleId></ArticleIdList></Reference><Reference><Citation>MacVicar T.D., Lane J.D. Impaired OMA1-dependent cleavage of OPA1 and reduced DRP1 fission activity combine to prevent mitophagy in cells that are dependent on oxidative phosphorylation. Pt 10J. Cell Sci. 2014;127:2313&#x2013;2325. doi: 10.1242/jcs.144337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.144337</ArticleId><ArticleId IdType="pmc">PMC4021475</ArticleId><ArticleId IdType="pubmed">24634514</ArticleId></ArticleIdList></Reference><Reference><Citation>Rottenberg H., Hoek J. The Mitochondrial Permeability Transition: Nexus of Aging, Disease and Longevity. Cells. 2021;10:79. doi: 10.3390/cells10010079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10010079</ArticleId><ArticleId IdType="pmc">PMC7825081</ArticleId><ArticleId IdType="pubmed">33418876</ArticleId></ArticleIdList></Reference><Reference><Citation>Fivenson E.M., Lautrup S.H., Sun N., Scheibye-Knudsen M., Stevnsner T., Nilsen H., Bohr V.A., Fang E.F. Mitophagy in neurodegeneration and aging. Neurochem. Int. 2017;109:202&#x2013;209. doi: 10.1016/j.neuint.2017.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2017.02.007</ArticleId><ArticleId IdType="pmc">PMC5565781</ArticleId><ArticleId IdType="pubmed">28235551</ArticleId></ArticleIdList></Reference><Reference><Citation>Choubey V., Cagalinec M., Liiv J., Safiulina D., Hickey M.A., Kuum M., Liiv M., Anwar T., Eskelinen E.L., Kaasik A. BECN1 is involved in the initiation of mitophagy: It facilitates PARK2 translocation to mitochondria. Autophagy. 2014;10:1105&#x2013;1119. doi: 10.4161/auto.28615.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.28615</ArticleId><ArticleId IdType="pmc">PMC4091171</ArticleId><ArticleId IdType="pubmed">24879156</ArticleId></ArticleIdList></Reference><Reference><Citation>Eum K.-H., Lee M. Targeting the autophagy pathway using ectopic expression of Beclin 1 in combination with rapamycin in drug-resistant v-Ha-ras-transformed NIH 3T3 cells. Mol. Cells. 2011;31:231&#x2013;238. doi: 10.1007/s10059-011-0034-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10059-011-0034-6</ArticleId><ArticleId IdType="pmc">PMC3932692</ArticleId><ArticleId IdType="pubmed">21350938</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowik M., Kampik N.B., Mihailova M., Eladari D., Wagner C.A. Induction of metabolic acidosis with ammonium chloride (NH4Cl) in mice and rats--species differences and technical considerations. Cell. Physiol. Biochem. 2010;26:1059&#x2013;1072. doi: 10.1159/000323984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000323984</ArticleId><ArticleId IdType="pubmed">21220937</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O., Bordoni M., Drufuca L., Diamanti L., Sproviero D., Trotti R., Bernuzzi S., La Salvia S., Gagliardi S., Ceroni M., et al. Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms. Dis. Models Mech. 2018;11:dmm031625. doi: 10.1242/dmm.031625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.031625</ArticleId><ArticleId IdType="pmc">PMC5897724</ArticleId><ArticleId IdType="pubmed">29419416</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105&#x2013;1116. doi: 10.1016/0896-6273(95)90259-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S., Otomo A., Kunita R., Suzuki-Utsunomiya K., Akatsuka A., Koike M., Aoki M., Uchiyama Y., Itoyama Y., Ikeda J.E. Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking. PLoS ONE. 2010;5:e9805. doi: 10.1371/journal.pone.0009805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009805</ArticleId><ArticleId IdType="pmc">PMC2842444</ArticleId><ArticleId IdType="pubmed">20339559</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J., Cortez C., Gan W.-B., Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Zhang X., Le W. Altered macroautophagy in the spinal cord of SOD1 mutant mice. Autophagy. 2008;4:290&#x2013;293. doi: 10.4161/auto.5524.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5524</ArticleId><ArticleId IdType="pubmed">18196963</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S. Autophagy in Spinal Cord Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis. J. Neuropathol. Exp. Neurol. 2011;70:349&#x2013;359. doi: 10.1097/NEN.0b013e3182160690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3182160690</ArticleId><ArticleId IdType="pubmed">21487309</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky D.J., Abdelmohsen K., Abe A., Abedin M.J., Abeliovich H., Acevedo Arozena A., Adachi H., Adams C.M., Adams P.D., Adeli K., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Autophagy. 2016;12:1&#x2013;222. doi: 10.1080/15548627.2015.1100356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1100356</ArticleId><ArticleId IdType="pmc">PMC4835977</ArticleId><ArticleId IdType="pubmed">26799652</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodolfo C., Campello S., Cecconi F. Mitophagy in neurodegenerative diseases. Neurochem. Int. 2018;117:156&#x2013;166. doi: 10.1016/j.neuint.2017.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2017.08.004</ArticleId><ArticleId IdType="pubmed">28797885</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiyama A., Okamoto K. PINK1/Parkin-mediated mitophagy in mammalian cells. Curr. Opin. Cell Biol. 2015;33:95&#x2013;101. doi: 10.1016/j.ceb.2015.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2015.01.002</ArticleId><ArticleId IdType="pubmed">25697963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mugume Y., Kazibwe Z., Bassham D. Target of Rapamycin in Control of Autophagy: Puppet Master and Signal Integrator. Int. J. Mol. Sci. 2020;21:8259. doi: 10.3390/ijms21218259.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218259</ArticleId><ArticleId IdType="pmc">PMC7672647</ArticleId><ArticleId IdType="pubmed">33158137</ArticleId></ArticleIdList></Reference><Reference><Citation>Coryell P.R., Goraya S.K., Griffin K.A., Redick M.A., Sisk S.R., Purvis J.E. Autophagy regulates the localization and degradation of p16 INK4a. Aging Cell. 2020;19:e13171. doi: 10.1111/acel.13171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13171</ArticleId><ArticleId IdType="pmc">PMC7370706</ArticleId><ArticleId IdType="pubmed">32662244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseinpour-Moghaddam K., Caraglia M., Sahebkar A. Autophagy induction by trehalose: Molecular mechanisms and therapeutic impacts. J. Cell. Physiol. 2018;233:6524&#x2013;6543. doi: 10.1002/jcp.26583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26583</ArticleId><ArticleId IdType="pubmed">29663416</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P., Cortese K., Crippa V., Cristofani R., Cicardi M.E., Ferrari V., Vezzoli G., Tedesco B., Meroni M., Messi E., et al. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. Autophagy. 2018;15:631&#x2013;651. doi: 10.1080/15548627.2018.1535292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2018.1535292</ArticleId><ArticleId IdType="pmc">PMC6526812</ArticleId><ArticleId IdType="pubmed">30335591</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>